Persistent Superior Vena Caval Syndrome Due to Totally Implantable Venous Access Systems

Hickman R.O. , Buckner C.D. , Clift R.A. , Sanders J.E. , Stewart P. , Thomas E.D. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871–5

Ball A.B.S. , Duncan F.J. , Davidson R.M. , Watkins R.M. , Hodson M.E. Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Resp Med 1989; 83: 429–31

Kariyawasam H.H. , Pepper J.R. , Hodson M.E. , Geddes D.M. Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period. Resp Med 2000; 94: 1161–5

Deerojanawong J. , Sawyer S.M. , Fink A.M. , Stokes K.B. , Robertson C.F. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax 1998; 53: 285–9

Brinker H. , Saeter G. Fifty-five years’ experience with a totally implanted system for intravenous chemotherapy. Cancer 1986; 57: 1124–9

Collinson J. , Haworth C. , O'Callaghan C. Recurrent venous thrombosis in a patient with cystic fibrosis. Pediatr Pulmionol 1995; 20: 410–12

Singh S.J. , Martin H.C.O. Insertion of implantable venous access device via inferior epigastric vein in cystic fibrosis children. Abstr 13th International CF Conference, Stockholm, 2000: 167